Mo1915 IT IS NOT COST EFFECTIVE TO USE PROPHYLACTIC ORAL VANCOMYCIN TO PREVENT RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN HOSPITALIZED PATIENTS

CI = 0.0030-0.011),respectively.According to meta-regression analyses, the risk of cancer development was not particularly affected by the use of concomitant medications such as steroids, immunomodulator and anti-TNF agents.Cumulative meta-analyses showed a decreasing trend in the incidence of these cancers in both CD and UC.Conclusion: In the present systematic review and meta-analysis, patients with pediatric IBD had an increased risk of cancer development compared to the general population, however, incidence appeared to be decreasing in recent years.The results of our study provide useful information for physicians managing pediatric and adolescent patients with IBD. Mo1913